Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Lipid Testing After Acute Myocardial Infarction

J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Lipid testing and high-intensity statin use were infrequent after acute myocardial infarction (MI), despite previous guidelines recommendations of low-density lipoprotein cholesterol (LDL-C) goal-directed statin therapy, a recent study found. Researchers evaluated the frequency of postdischarge lipid testing and high-intensity statin use among MI patients discharged on a statin during Adult Treatment Panel third report (ATP III) guidelines era. 11,046 patients with MI aged ≥65 years were included and multivariable regression was used to evaluate the association between lipid testing and 1-year high-intensity statin use. Among the findings:

  • Only 21% of MI patients were discharged on a high-intensity statin.
  • 44% of patients discharged on a statin underwent lipid testing at 90 days.
  • Follow-up lipid testing rates were 47% among patients with in-hospital LDL-C ≥100 mg/dL and 47% among newly prescribed statin recipients.
  • By 1 year, only 14% of patients were on high-intensity statins.

Citation:

Wang WT, Hellkamp A, Doll JA. Lipid testing and statin dosing after acute myocardial infarction. [Published online ahead of print January 25, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.117.006460.

This Week's Must Reads

Lipid Testing After Acute Myocardial Infarction, J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Clinical Pharmadynamics of Evolocumab, Clin Pharmacokinet; ePub 2018 Jan 20; Kasichayanula, et al

Lipoproteins & CV Outcomes in Dialysis Patients, J Clin Lipidol; ePub 2017 Dec 26; Kaysen, et al

Is Dual Lipid-Lowering Therapy Better?, Atherosclerosis; 2018 Feb; Gragnano, et al

sLOX-1 in Ischemic Stroke & Transient Ischemic Attack, J Am Heart Assoc; ePub 2018 Jan 12; Skarpengland, et al

Must Reads in Hypercholesterolemia

Lipid Testing After Acute Myocardial Infarction, J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Clinical Pharmadynamics of Evolocumab, Clin Pharmacokinet; ePub 2018 Jan 20; Kasichayanula, et al

Lipoproteins & CV Outcomes in Dialysis Patients, J Clin Lipidol; ePub 2017 Dec 26; Kaysen, et al

Is Dual Lipid-Lowering Therapy Better?, Atherosclerosis; 2018 Feb; Gragnano, et al

sLOX-1 in Ischemic Stroke & Transient Ischemic Attack, J Am Heart Assoc; ePub 2018 Jan 12; Skarpengland, et al